University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 3C-18-7


A Phase 1/2 Study of Durvalumab and Monalizumab in Adult Subjects with Select Advanced Solid Tumors

Type: Treatment
Phase: Phase I/II
Status: Open to Accrual
Treatments: Chemotherapy: Systemic, Immunotherapy
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Heinz Josef Lenz, M.D.
Other Trial Staff:  Yan Ning, D.M., Cristina De Leon, Coordinator, Deborah Fridman, Coordinator, Chi Nguyen, Coordinator, Maria Sharma, Coordinator, Leila Andres, Coordinator, Fahim Raian, D.M., Charlean Ketchens, R.N., Jiayi Jiang, D.M., Raluca Agafitei, Coordinator, Mary Ordaz, D.M., Xiomara Menendez, R.N., Noureddine Miloud, D.M., Niranjan Bhatt, D.M., Rabia Rehman, Coordinator, Sodech Kim, Coordinator, Atessa Kiani, Coordinator, Diana Oganyesyan, Coordinator, Janelle Luevano, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.